Peter H. Dube
Boehringer Ingelheim (United States)
ORCID: 0000-0002-8755-3737Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M pro and cathepsin L”.
Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia A. Townsend, Xiangzhi Meng +12 more
Derek Wallace, Bin Wang, Irving Salinas, Adriana Paola Chapparo, Hudson R. Smith +5 more
Peter H. Dube, Ryan P. Gilley
Ashleigh N. Riegler, Alexander S. Jureka, Ryan P. Gilley, Jeffrey D. Brand, John E. Trombley +6 more
Gema D. Barrera, Liping Yan, Hamad H. Alanazi, Edward G. Brooks, Peter H. Dube +8 more
Harinder Singh, Maryann P. Platt, Yanbao Yu, Yi‐Han Lin, Yuji Ikeno +5 more
Maryann P. Platt, Ryan P. Gilley, David Brown, Peter H. Dube, Yanbao Yu +2 more
Elsa D. Ibáñez-Prada, Cristian C. Serrano-Mayorga, Benjamín L. Sievers, Maeve A. Engelbride, Surya Padmanabhan +10 more
Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia A. Townsend, Xiangzhi Meng +12 more
Elsa D. Ibáñez-Prada, Cristian C. Serrano-Mayorga, Benjamín L. Sievers, Maeve A. Engelbride, Surya Padmanabhan +10 more